04:48
AIM-LO: Engaging With Your Patients about Selection of Injectable Therapies for LDL-C Reduction
Broadcast Date
Presenter
Beth L. Abramson, MD, MSc, FRCPC, FACC
Therapeutic Area
Cardiovascular
Dr. Beth Abramson highlights the benefits of actively involving patients in decision-making when selecting an injectable therapy for LDL-C reduction in secondary prevention of ASCVD, and shares how to best navigate those discussions.
